Product Code: ETC9971387 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Neuromonitoring Devices Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Neuromonitoring Devices Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Neuromonitoring Devices Market - Industry Life Cycle |
3.4 United States (US) Neuromonitoring Devices Market - Porter's Five Forces |
3.5 United States (US) Neuromonitoring Devices Market Revenues & Volume Share, By Product, 2021 & 2031F |
4 United States (US) Neuromonitoring Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in the United States |
4.2.2 Technological advancements leading to the development of more sophisticated neuromonitoring devices |
4.2.3 Growing awareness among healthcare professionals about the benefits of neuromonitoring in surgical procedures |
4.3 Market Restraints |
4.3.1 High cost associated with neuromonitoring devices and procedures |
4.3.2 Limited reimbursement policies for neuromonitoring services |
4.3.3 Stringent regulatory requirements for the approval of neuromonitoring devices |
5 United States (US) Neuromonitoring Devices Market Trends |
6 United States (US) Neuromonitoring Devices Market, By Types |
6.1 United States (US) Neuromonitoring Devices Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Neuromonitoring Devices Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 United States (US) Neuromonitoring Devices Market Revenues & Volume, By Intracranial Pressure Monitoring, 2021- 2031F |
6.1.4 United States (US) Neuromonitoring Devices Market Revenues & Volume, By Cerebral Oximeter, 2021- 2031F |
6.1.5 United States (US) Neuromonitoring Devices Market Revenues & Volume, By Near Infrared Spectroscopy, 2021- 2031F |
6.1.6 United States (US) Neuromonitoring Devices Market Revenues & Volume, By Speckle Imaging, 2021- 2031F |
6.1.7 United States (US) Neuromonitoring Devices Market Revenues & Volume, By Doppler Ultrasound, 2021- 2031F |
6.1.8 United States (US) Neuromonitoring Devices Market Revenues & Volume, By EEG, 2021- 2031F |
6.1.9 United States (US) Neuromonitoring Devices Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 United States (US) Neuromonitoring Devices Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Neuromonitoring Devices Market Import-Export Trade Statistics |
7.1 United States (US) Neuromonitoring Devices Market Export to Major Countries |
7.2 United States (US) Neuromonitoring Devices Market Imports from Major Countries |
8 United States (US) Neuromonitoring Devices Market Key Performance Indicators |
8.1 Adoption rate of neuromonitoring devices in hospitals and surgical centers |
8.2 Number of clinical studies and research publications supporting the efficacy of neuromonitoring devices |
8.3 Investment trends in RD for neuromonitoring technologies |
9 United States (US) Neuromonitoring Devices Market - Opportunity Assessment |
9.1 United States (US) Neuromonitoring Devices Market Opportunity Assessment, By Product, 2021 & 2031F |
10 United States (US) Neuromonitoring Devices Market - Competitive Landscape |
10.1 United States (US) Neuromonitoring Devices Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Neuromonitoring Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |